Researcher admits plot to steal GSK secrets to sell in China

Researcher admits plot to steal GSK secrets to sell in China


A cancer researcher pleaded guilty Friday to conspiring to steal biopharmaceutical trade secrets from GlaxoSmithKline in what prosecutors said was a scheme that involved plans to set up companies in China to market them. Yu Xue entered a guilty plea in federal court to a single conspiracy count.



from Biotech News
Share:

Us Stocks-Wall St sluggish on trade concerns; Apple, Amazon lift Nasdaq

Us Stocks-Wall St sluggish on trade concerns; Apple, Amazon lift Nasdaq


The S&P 500 and the Dow Jones Industrial Average were largely flat on Friday hit by concerns about ongoing trade talks between the United States and other major economies, but gains in Apple and Amazon lifted the Nasdaq. Wall Street's rally came to a halt on Thursday after a report that U.S. President Donald Trump was ready to impose tariffs on $200 billion more of Chinese goods next week.



from Biotech News
Share:

Move over, Massachusetts: California takes top spot for biotech R&D jobs

Move over, Massachusetts: California takes top spot for biotech R&D jobs


A report published by the trade group MassBio showed that the number of California residents employed in biotech research and development job swelled to more than 39,000 last year, beating Massachusetts by 3,300 workers. The two states have engaged in a long-running and friendly battle to declare dominance in the biotech industry, which they use to attract more companies and more jobs.



from Biotech News
Share:

Bristol-Myers Squibb Co (BMY) Shares Sold by FDx Advisors Inc.

Bristol-Myers Squibb Co (BMY) Shares Sold by FDx Advisors Inc.


FDx Advisors Inc. lessened its holdings in shares of Bristol-Myers Squibb Co by 76.0% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 7,675 shares of the biopharmaceutical company's stock after selling 24,330 shares during the quarter.



from Biotech News
Share:

Norfolk biotech startup Embody gets investment boost

Norfolk biotech startup Embody gets investment boost


A Norfolk-based biotech company is getting an additional $1.5 million from area investment groups to develop a cutting-edge treatment for tendon and ligament injuries. 757 Angels and the Center for Innovative Technology are the biggest of the latest investors, putting in $660,000 and $250,000, respectively.



from Biotech News
Share:

FDA approves two new HIV drugs from Merck

FDA approves two new HIV drugs from Merck


Merck & Co Inc said on Thursday the U.S. Food And Drug Administration approved two of its HIV oral drugs, nearly two months ahead of schedule. FILE PHOTO: A view shows the U.S. Food and Drug Administration headquarters in Silver Spring, Maryland August 14, 2012.



from Biotech News
Share:

Press release distribution, EDGAR filing, XBRL, regulatory filings

Press release distribution, EDGAR filing, XBRL, regulatory filings


According to the report, the Global Securi... )--Actelion Pharmaceuticals Ltd, one of the Janssen Pharmaceutical Companies of Johnson & Johnson, today announced the submission of a Type II Variation to... )--Donnelley Financial Solutions announced today its participation at the DA Davidson Vertical Technology Conference on Wednesday September 5, 2018 at the New Yo... )--The "Oligonucleotide Synthesis Market by Offering, by Application, by End User, by Geography - Global Market Size, Share, Development, Growth and Demand Forecast, 2013 - 20... )--The "Audiology Devices - Global Market Outlook " report has been added to ResearchAndMarkets.com's offering.



from Biotech News
Share:

Stada-Chef verlässt Unternehmen doch komplett

Stada-Chef verlässt Unternehmen doch komplett


(dpa) Stada-Chef Claudio Albrecht verlässt den Pharmakonzern nach seinem planmäßigen Ausscheiden doch komplett. Ursprünglich hatte es geheißen, dass der Manager, der am Samstag (1. September) abtritt, dann in eine «nicht-geschäftsführende Position» innerhalb des Unternehmens wechselt. Spekuliert wor...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.
Share:

Finanzen: Riester-Rente wechseln : Riester kündigen

Viele Riester-Sparer stecken in einem teuren Vertrag mit wenig Renditechancen. Sie sollten über eine Wechsel nachdenken. Zwei Möglichkeiten kommen infrage.

from Finanztip Feed
Supported by Video Collection
Share:

The Daily Biotech Pulse: Verastem Gets New CFO, Mesoblast Earnings,...

The Daily Biotech Pulse: Verastem Gets New CFO, Mesoblast Earnings,...


Japanese pharma giant Eisai announced its South Korean subsidiary received approval for the kinase inhibitor LENVIMA as a single agent for the first-line treatment of patients with unresectable hepatocellular carcinoma. "LENVIMA is the first new treatment option approved in ten years as a first-line systemic treatment for HCC in South Korea," Eisai said.



from Biotech News
Share:

Deadly salmonella outbreak linked to kosher chicken Source: Cox Media Group

Deadly salmonella outbreak linked to kosher chicken Source: Cox Media Group


Salmonella has sickened 17 people in four states and one person has died, according to the Atlanta-based Centers for Disease Control and Prevention. Eight people reportedly were so sick that they had to be hospitalized.



from Biotech News
Share:

Arena Pharmaceuticals to Present at Upcoming Investor Conferences

Arena Pharmaceuticals to Present at Upcoming Investor Conferences


SAN DIEGO, Aug. 29, 2018 /PRNewswire/ -- Arena Pharmaceuticals, Inc. today announced that members of its senior management team will participate in the upcoming investor conferences: Wells Fargo Securities Global Healthcare Conference - Presenting on Wednesday, September 5 at 2:25 p.m. EDT in BostonCiti Annual Biotech Conference - Hosting investor meetings on Thursday, September 6 in BostonMorgan Stanley Annual Global Healthcare Conference - Presenting on Friday, September 14 at 10:30 a.m. EDT in New York City A live audio webcast of the presentations will be available under the investor relations section of Arena's website at www.arenapharm.com . A replay of the presentation will be available for 30 days following the event.



from Biotech News
Share:

Investment Analysts' Recent Ratings Updates for Global Partners

Investment Analysts' Recent Ratings Updates for Global Partners


According to Zacks, "Global Partners is a Delaware limited partnership formed by affiliates of the Slifka family. Global Partners owns, controls or has access to one of the largest terminal networks of refined petroleum products in New England.



from Biotech News
Share:

Gilead Sciences Appoints Laura Hamill as Executive Vice President, Worldwide Commercial Operations

Gilead Sciences Appoints Laura Hamill as Executive Vice President, Worldwide Commercial Operations


Aug 28, 2018--Gilead Sciences, Inc. today announced that Laura Hamill will join the company as Executive Vice President, Worldwide Commercial Operations, and will become a member of Gilead's senior leadership team. Ms. Hamill is an experienced leader with significant expertise in managing the complexity of commercial operations at a large biopharmaceutical company, including driving strategic planning, delivering operating results, executing on product launches and strategic partnerships, and leading market development.



from Biotech News
Share:

Finanzen: Mietwagen-Test 2015 : Mietwagen-Test 2015

Buchen Sie Ihren Mietwagen so früh wie möglich. Dann kostet er am wenigsten. Welche Preisvergleichsseiten gut sind und welche Tricks es gibt.

from Finanztip Feed
Supported by Video Collection
Share:

World stock index at five-and-a-half-month high as trade fears wane

World stock index at five-and-a-half-month high as trade fears wane


A major global stock index jumped to a 5-1/2-month high on Wednesday as optimism on the potential for U.S. trade deals cleared the path for technology stocks to resume their leadership mantle. Traders work on the floor of the New York Stock Exchange in New York, U.S., August 28, 2018.



from Biotech News
Share:

FOCUS-Europe ready to cash in on cheap copies of AbbVie biotech drug

FOCUS-Europe ready to cash in on cheap copies of AbbVie biotech drug


U.S. drugmaker AbbVie ABBV.N faces a crunch moment in Europe in mid-October when less-expensive copies of its $18-billion-a-year biologic drug Humira - the world's best-selling prescription medicine - hit the market. A screen displays the share price for pharmaceutical maker AbbVie on the floor of the New York Stock Exchange July 18, 2014.



from Biotech News
Share:

90 Jahre Antibiotika - eine Wunderwaffe droht stumpf zu werden

90 Jahre Antibiotika - eine Wunderwaffe droht stumpf zu werden


(dpa) Krebstherapien, Kniegelenkersatz, eine neue Niere - was für Millionen Patienten weltweit selbstverständlich scheint, wäre ohne die Entdeckung von Antibiotika vor 90 Jahren weitaus riskanter. Mit solchen Substanzen werden lebensgefährliche Bakterien, die sich bei Eingriffen verbreiten können, i...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.
Share:

STD rates on the rise around the country

STD rates on the rise around the country


Sexually transmitted diseases are on the rise in this country. That's according to new data just released by the Centers for Disease Control and Prevention in Atlanta.



from Biotech News
Share:

Biotech Analysts Reap Windfall

Biotech Analysts Reap Windfall


Investment banks Leerink Partners LLC, Cantor Fitzgerald & Co. and Jefferies Group LLC have lured top-name biotech analysts from large banks with guaranteed pay packages worth $3 million or more and contracts extending as long as three or four years, say people familiar with the matter.



from Biotech News
Share:

Emergent BioSolutions to buy Narcan maker Adapt Pharma

Emergent BioSolutions to buy Narcan maker Adapt Pharma


REUTERS: Emergent BioSolutions Inc said on Tuesday it would buy privately held Adapt Pharma, beefing up its portfolio with Narcan, the only FDA approved needle-free emergency opioid overdose treatment. Addiction to opioids - mainly prescription painkillers, heroin and fentanyl - has emerged as a serious public health crisis in the United States, especially in rural areas.



from Biotech News
Share:

Staying at the Grande Colonial La Jolla Cove, San Diego

Staying at the Grande Colonial La Jolla Cove, San Diego


On the go and no time to finish that story right now? Your News is the place for you to save content to read later from any device. Register with us and content you save will appear here so you can access them to read later.



from Biotech News
Share:

Chest pain drug falls short in preventing first episode of ventricular arrhythmia or death

Chest pain drug falls short in preventing first episode of ventricular arrhythmia or death


IMAGE: A trial of more than 1,000 patients with implantable cardioverter defibrillators found that the drug ranolazine was safe but didn't decrease the... view A clinical trial of more than 1,000 patients with implantable cardioverter defibrillators found that the drug ranolazine was safe but didn't significantly decrease the likelihood of the first occurrence of ventricular tachycardia, ventricular fibrillation or death in this high-risk population. The study was published recently in JACC , the Journal of the American College of Cardiology .



from Biotech News
Share:

EU-Kommission billigt Verkauf von Merck-Sparte an Procter & Gamble

EU-Kommission billigt Verkauf von Merck-Sparte an Procter & Gamble


(dpa) Der Darmstädter Pharmakonzern Merck hat von der EU-Kommission die Genehmigung zum Verkauf seiner Sparte für rezeptfreie Arzneien an das US-Unternehmen Procter & Gamble bekommen. Man habe keine Wettbewerbsbedenken, erklärte die Brüsseler Behörde am Dienstag. Merck hatte den Verkauf im Wert von ...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.
Share:

LT breathing tubes after cardiac arrest could save 10,000 more lives

LT breathing tubes after cardiac arrest could save 10,000 more lives


By comparing two breathing techniques in real-world situations, investigators were able to identify a better survival rate for patients who received the laryngeal tube device, findings that could potentially save more than 10,000 lives annually. DALLAS Aug. 28, 2018 Heart attack patients given a different type of breathing tube by paramedics had better survival rates than those treated by traditional intubation breathing tube methods findings that could potentially save more than 10,000 lives annually, researchers report.



from Biotech News
Share:

Bristol-Myers Squibb Appoints Christopher Boerner Executive Vice President and Chief Commercial Officer

Bristol-Myers Squibb Appoints Christopher Boerner Executive Vice President and Chief Commercial Officer


Aug 28, 2018-- Bristol-Myers Squibb Company today announced that Christopher Boerner, Ph.D., has been appointed executive vice president and chief commercial officer, effective immediately. Boerner succeeds Murdo Gordon, who departed the company on August 3, 2018, to pursue another opportunity.



from Biotech News
Share:

COMSAT and Avanti Communications plc Sign Seven Year Master Distribution Agreement

COMSAT and Avanti Communications plc Sign Seven Year Master Distribution Agreement


WASHINGTON & LONDON-- --Aug 28, 2018--COMSAT, a leader in satellite connectivity to the US DoD, has announced a seven year Master Distribution Agreement with London-listed Avanti Communications plc . COMSAT will benefit from the Avanti advanced satellite fleet and particularly from the Hylas 4 satellite, a High-Throughput Satellite , focused on the Middle East and Africa.



from Biotech News
Share:

Insider Selling: Quidel Co. (QDEL) Director Sells 3,886 Shares of Stock

Insider Selling: Quidel Co. (QDEL) Director Sells 3,886 Shares of Stock


Quidel Co. Director Mary Lake Ph D. Polan sold 3,886 shares of Quidel stock in a transaction dated Thursday, August 23rd.



from Biotech News
Share:

Death on the Operating Table: How Patients Can Protect Themselves

Death on the Operating Table: How Patients Can Protect Themselves


According to a recent study by Johns Hopkins, medical mistakes lead to the death of more than 250,000 people in the United States yearly, this figure, exceeds the U.S. Centers for Disease Control and Prevention's third leading cause of death - respiratory disease, which kills close to 150,000 people per year. Some other studies would claim the number of yearly deaths caused by medical mistakes is as much as 440, 000.



from Biotech News
Share:

Finanzen: Mietwagen : Mietwagen

Bei den großen Vermietern oder erst am Urlaubsort einen Wagen zu mieten, ist zu teuer. Wir zeigen Ihnen, wie Sie vorher im Internet fündig werden.

from Finanztip Feed
Supported by Video Collection
Share:

World stock index at highest in over five months on trade deal

World stock index at highest in over five months on trade deal


An index of major world stock markets rose to its highest level in more than five months on Monday after the United States and Mexico struck an agreement that lowers trade tensions. Traders work on the floor of the New York Stock Exchange in New York, U.S., August 22, 2018.



from Biotech News
Share:

Finanzen: Mietwagentest 2015 : Mietwagentest 2015

Buchen Sie Ihren Mietwagen so früh wie möglich. Dann kostet er am wenigsten. Welche Preisvergleichsseiten gut sind und welche Tricks es gibt.

from Finanztip Feed
Supported by Video Collection
Share:

Pfizer präsentiert positive Daten für Hoffnungsträger

Pfizer präsentiert positive Daten für Hoffnungsträger


(dpa-AFX) Der US-Pharmakonzern Pfizer hat in einer Studie die Wirksamkeit seines Hoffnungsträgers Tafamidis belegen können. Wie der Konzern am Montag mitteilte, konnte das Mittel bei Patienten mit einem seltenen Herzleiden (Transthyretin-assoziierter Kardiomyopathie) das Todesrisiko um 30 Prozent se...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.
Share:

CytRx Corporation to Present at the H.C. Wainwright & Co. 20th Annual ...

CytRx Corporation to Present at the H.C. Wainwright & Co. 20th Annual ...


CytRx Corporation , a biopharmaceutical research and development company specializing in oncology, today announced that Mr. Eric Curtis, President and Chief Operating Officer, will present at the H.C. Wainwright 20th Annual Global Investment Conference. The presentation will occur on Wednesday, September 5 at 11:40 A.M. Eastern Daylight Time at the St. Regis Hotel in New York City.



from Biotech News
Share:

Evotec und CENTOGENE gehen Partnerschaft im Bereich seltener genetischer Erkrankungen ein

Evotec und CENTOGENE gehen Partnerschaft im Bereich seltener genetischer Erkrankungen ein


Evotec AG gab bekannt, dass CENTOGENE AG und Evotec eine globale strategische Vereinbarung für gemeinsame Wirkstoffforschungsprojekte eingegangen sind. Innerhalb dieser Projekte sollen Substanzen für die Behandlung seltener genetischer Erkrankungen entwickelt werden. Evotec und CENTOGENE haben die Z...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.
Share:

How an unsolved murder mystery changed our pill bottles

How an unsolved murder mystery changed our pill bottles


It started with a series of mysterious deaths in the Chicago area on September 29, 1982: a 12-year-old in Elk Grove Village, a postal worker in Arlington Heights, a new mother of four in Winfield. "We didn't know what was happening, but everybody thought he died of heart attack," said Joseph Janus, brother of postal worker Adam Janus.



from Biotech News
Share:

Bayer, J&J's bid to further widen use of Xarelto hits snag

Bayer, J&J's bid to further widen use of Xarelto hits snag


Bayer and Johnson & Johnson's campaign to widen the patient group for their heart drug Xarelto hit a snag when two smaller studies failed to show a statistically reliant benefit. The logo of Bayer AG is pictured at the Bayer Healthcare subgroup production plant in Wuppertal, Germany February 24, 2014.



from Biotech News
Share:

New Jackson Lab facility could be catalyst to grow biotech business in Ellsworth

New Jackson Lab facility could be catalyst to grow biotech business in Ellsworth


A biotechnology firm is expanding as part of the city's plans to create spin-offs to a $200 million mice breeding center that opened in Ellsworth last week. GenoTyping Center of America will remain headquartered at the Union River Center for Innovation of Ellsworth, but much of its genetic testing of research animals has moved to Waterville because one of its founders lives near there, GenoType owner Kat Taylor said.



from Biotech News
Share:

Finanzen: Darlehensrechner Baufinanzierung : Darlehensrechner

Viele träumen von den eigenen vier Wänden. Doch davor steht oft ein wenig Rechenarbeit. Unsere handlichen Rechner zur Baufinanzierung helfen Ihnen dabei.

from Finanztip Feed
Supported by Video Collection
Share:

Finanzen: Ihr Finanztip-Finanzierungsrechner : Finanzierungsrechner

Viele träumen von den eigenen vier Wänden. Ein Finanzierungrechner hilft Ihnen, die finanzielle Belastung bei der Baufinanzierung besser einzuschätzen.

from Finanztip Feed
Supported by Video Collection
Share:

Finanzen: Baukreditrechner : Baukreditrechner

Viele Kunden berechnen ihren Baukredit heute zunächst selbst, bevor Sie zum Berater gehen. Ein Baukreditrechner hilft bei den richtigen Eingaben.

from Finanztip Feed
Supported by Video Collection
Share:

The Week Ahead In Biotech: Conferences, PDUFA Dates And Clinical Trial Results

The Week Ahead In Biotech: Conferences, PDUFA Dates And Clinical Trial Results


Biotech stocks saw a resurgence this week, as a post-earnings follow-up rally and company-specific news offered support. The iShares NASDAQ Biotechnology Index gained about 1.5 percent.



from Biotech News
Share:

Taro Pharmaceutical Industries Ltd. (TARO) Position Lowered by Systematic Financial Management LP

Taro Pharmaceutical Industries Ltd. (TARO) Position Lowered by Systematic Financial Management LP


Systematic Financial Management LP reduced its stake in Taro Pharmaceutical Industries Ltd. by 15.8% during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission . The firm owned 11,830 shares of the company's stock after selling 2,215 shares during the quarter.



from Biotech News
Share:

Finanzen: PV-Steuer : Photovoltaik Steuer auf Solarstrom

Der günstigste Strom, ist der, den Sie selbst mit einer Photovoltaik-Anlage erzeugen. Verkaufen Sie Teile davon, müssen Sie Steuern zahlen. Finanztip erklärt, was zu beachten ist.

from Finanztip Feed
Supported by Video Collection
Share:

Novartis erhält EU-Zulassung für Gentherapie

Novartis erhält EU-Zulassung für Gentherapie


(dpa-AFX) Der Schweizer Pharmakonzern Novartis hat für seine Gentherapie Kymriah die Zulassung von der Europäischen Kommission erhalten. Künftig darf die Therapie in der EU zur Behandlung zweier bestimmter Blutkrebsformen angewendet werden. Dabei handele es sich um die akute lymphoblastische Leukämi...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.
Share:

Spahn erwägt nach Pharmaskandalen Gesetzesänderungen

Spahn erwägt nach Pharmaskandalen Gesetzesänderungen


(dpa) Nach den jüngsten Pharmaskandalen um gestohlene oder verunreinigte Medikamente erwägt Bundesgesundheitsminister Jens Spahn größere Kompetenzen für den Bund. Mit Blick auf den Fall von Blutdrucksenkern mit dem Wirkstoff Valsartan, die mit einem potenziell krebserregenden Stoff verunreinigt ware...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.
Share:

Finanzen: Hauskreditrechner : Kreditrechner Haus

Viele Kunden möchten ihren Hauskredit online berechnen. Mit einem Hauskreditrechner erfahren Sie, wie teuer der Hausbau wirklich wird.

from Finanztip Feed
Supported by Video Collection
Share:

Weight-loss drug Belviq seems safe for heart, study finds

Weight-loss drug Belviq seems safe for heart, study finds


This undated image provided by Eisai in August 2018 shows the company's Belviq medication. For the first time, a study found that a drug can help people lose weight and keep it off for several years without raising their risk for heart problems.



from Biotech News
Share:

Survey unveils sex abuse of Native American women in Seattle

Survey unveils sex abuse of Native American women in Seattle


A 2010 survey shows 94 percent of the 148 women interviewed, all of whom identified as American Indian or Alaska Native, reported they had been raped or were coerced into sex at least once in their lives. The Seattle Times reports the survey, co-produced by the health institute and the Centers for Disease Control and Prevention , documented the experiences of sexual violence among Native-American women living in Seattle.



from Biotech News
Share:

From near non-existence to major biotech star: Neurocrine's journey

From near non-existence to major biotech star: Neurocrine's journey


For Neurocrine Biosciences, 2018 is shaping up as the year just about everything went right. The recent good news caps a dramatic recovery for the San Diego biotech company, that at one point came close to running out of money.



from Biotech News
Share:

Reviewing Aradigm

Reviewing Aradigm


Aradigm and CHF Solutions are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their analyst recommendations, risk, valuation, earnings, profitability, institutional ownership and dividends. Aradigm has a beta of 0.46, meaning that its stock price is 54% less volatile than the S&P 500.



from Biotech News
Share:

Ex-CDC director Frieden accused of groping woman's buttocks

Ex-CDC director Frieden accused of groping woman's buttocks


One of the nation's most respected medical experts, who led the U.S. Centers for Disease Control and Prevention, entered a courtroom on Friday in handcuffs, arrested on sexual-harassment charges after a woman accused him of grabbing her behind late one night last year. Dr. Thomas Frieden, who for years informed the public about dangers to their health, sat stone-faced as a judge warned him not to approach the woman, who accused him of groping her on Oct. 20, 2017, in his Brooklyn home.



from Biotech News
Share:

MediBloc [ERC20] (MEDX) 24 Hour Volume Hits $1.89 Million

MediBloc [ERC20] (MEDX) 24 Hour Volume Hits $1.89 Million


MediBloc [ERC20] traded up 1.1% against the dollar during the one day period ending at 19:00 PM E.T. on August 25th. During the last seven days, MediBloc [ERC20] has traded 10.9% higher against the dollar.



from Biotech News
Share:

Regeneron Pharmaceuticals Inc (REGN) Shares Sold by Sei Investments Co.

Regeneron Pharmaceuticals Inc (REGN) Shares Sold by Sei Investments Co.


Sei Investments Co. lowered its stake in Regeneron Pharmaceuticals Inc by 35.3% during the second quarter, according to its most recent 13F filing with the SEC.



from Biotech News
Share:

GlaxoSmithKline plc (GSK) Stake Lessened by First Allied Advisory Services Inc.

GlaxoSmithKline plc (GSK) Stake Lessened by First Allied Advisory Services Inc.


First Allied Advisory Services Inc. reduced its position in shares of GlaxoSmithKline plc by 11.1% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 47,774 shares of the pharmaceutical company's stock after selling 5,941 shares during the period.



from Biotech News
Share:

UTA professor to develop hydrogel that promotes cardiac repair after heart attacks

UTA professor to develop hydrogel that promotes cardiac repair after heart attacks


A UTA bioengineering professor has won a new $460,000 grant from the National Institutes of Health to develop a biodegradable and bioactive hydrogel to repair heart tissue after heart attacks. "Heart attacks, or myocardial infarction, is a leading cause of morbidity and mortality worldwide," said UTA bioengineering professor Yi Hong, who is leading the research project.



from Biotech News
Share:

Broken water main floods La Jolla streets

Broken water main floods La Jolla streets


Around 5 p.m. Friday San Diego Water crews responded to reports of flooding at the intersection of Girard Avenue and Pearl Street. "I mean it was gushing out like a geyser it was really wild, now here I come back 20 minutes later and what a muddy horrible mess, but you have to imagine the power to raise the sidewalk into a point like that," La Jolla Resident Nancy Woelfel said.



from Biotech News
Share:

Death on the Operating Table: How Patients Can Protect Themselves

Death on the Operating Table: How Patients Can Protect Themselves


According to a recent study by Johns Hopkins, medical mistakes lead to the death of more than 250,000 people in the United States yearly,this figure, exceeds the U.S. Centers for Disease Control and Prevention's third leading cause of death - respiratory disease, which kills close to 150,000 people per year. Some other studies would claim the number of yearly deaths caused by medical mistakes is as much as 440, 000.



from Biotech News
Share:

Origin Agritech eyes biotech corn seed market in China

Origin Agritech eyes biotech corn seed market in China


Origin Agritech Ltd., a Chinese agricultural technology company, said it has initiated cooperation programs with other seed suppliers in China as part of a broad effort to integrate the company's GMO traits with the seed varieties of other suppliers. "This is a significant step forward for the commercialization of our GMO technologies," said James Chen, PhD, chief executive officer of Origin.



from Biotech News
Share:

Indiana experiences record year for drug overdose deaths

Indiana experiences record year for drug overdose deaths


A preliminary federal report finds that Indiana had a record number of drug overdose deaths last year as more than 1,800 people succumbed to overdoses.



from Biotech News
Share:

How an unsolved murder mystery changed our pill bottles

How an unsolved murder mystery changed our pill bottles


It started with a series of mysterious deaths in the Chicago area on September 29, 1982: a 12-year-old in Elk Grove Village, a postal worker in Arlington Heights, a new mother of four in Winfield. "We didn't know what was happening, but everybody thought he died of heart attack," said Joseph Janus, brother of postal worker Adam Janus.



from Biotech News
Share:

Nikkei rises as weak yen helps mood; Eisai soars

Nikkei rises as weak yen helps mood; Eisai soars


Japan's Nikkei rose on Friday as a weaker yen supported sentiment, with the pharmaceutical sector leading gains after a report that Eisai moved forward its mid-term profit goal by one year. The Nikkei share average was up 0.4 percent at 22,488.68 points by the midday break.



from Biotech News
Share:

Ex-Centers for Disease Control head Thomas Frieden arrested in sex abuse probe

Ex-Centers for Disease Control head Thomas Frieden arrested in sex abuse probe


Tom Frieden is shown testifying on Capitol Hill in Washington on July 13, 2016, when he was director of the Centers for Disease Control and Prevention. Frieden turned himself in to face charges, the New York Police Department said.



from Biotech News
Share:

PTC Therapeutics Successfully Completes Acquisition of Agilis Biotherapeutics

PTC Therapeutics Successfully Completes Acquisition of Agilis Biotherapeutics


PTC Therapeutics, Inc. , today announced that it has successfully completed the acquisition of Agilis Biotherapeutics, Inc., a private biotechnology company focused on the advancement of innovative gene therapy programs for rare genetic disorders that affect the central nervous system . "We are excited to complete the acquisition and welcome the Agilis employees to PTC," said Stuart W. Peltz, Ph.D., Chief Executive Officer, PTC Therapeutics, Inc. "We have added a team with exceptional gene therapy experience, a targeted micro-delivery gene therapy platform that has demonstrated durable clinical benefit, as well as gene therapy manufacturing and R&D capabilities.



from Biotech News
Share:

Bayer CEO Tries to Calm Fears Over Monsanto Verdict

Bayer CEO Tries to Calm Fears Over Monsanto Verdict


Bayer AG Chief Executive Officer Werner Baumann sought to soothe investors' worries after a $289 million jury award over the controversial weed-killer Roundup, saying the $66 billion purchase of Monsanto Co. still makes sense.



from Biotech News
Share:

WVU researchers working to stop cancer-growth protein

WVU researchers working to stop cancer-growth protein


Courtesy of WVU Today Yehenew Agazie, an associate professor of biochemistry at the WVU School of Medicine, received a $1.6 million grant from the National Institutes of Health to investigate a new breast cancer treatment that is especially effective against recurrent tumors.



from Biotech News
Share:

AstraZeneca inhaler lags GSK drug in lung disease trial

AstraZeneca inhaler lags GSK drug in lung disease trial


A new AstraZeneca inhaler for chronic lung disease has proved worse than a rival GlaxoSmithKline product in a clinical trial, a result AstraZeneca said was inconsistent with earlier findings. FILE PHOTO: The logo of AstraZeneca is seen on medication packages in a pharmacy in London April 28, 2014.



from Biotech News
Share:

Financial Advocates Investment Management Raises Stake in Johnson & Johnson

Financial Advocates Investment Management Raises Stake in Johnson & Johnson


Financial Advocates Investment Management increased its position in Johnson & Johnson by 12.8% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission . The firm owned 32,309 shares of the company's stock after buying an additional 3,667 shares during the period.



from Biotech News
Share:

Biotech firm share price up 12% after positive AGM and China deals

Biotech firm share price up 12% after positive AGM and China deals


SHARES in biotechnology specialist Collagen Solutions rose by 12 per cent as the company said it is on course to meet its targets this year year at its AGM. The share price of the Glasgow -based developer and manufacturer of medical grade biomaterials and regenerative medicines was up at 4.20p by late afternoon after the 11am meeting.



from Biotech News
Share:

Finanzen: Bafög : Bafög

Ein Studium oder eine Ausbildung kostet. Wer es sich nicht leisten kann, wird vom Staat unterstützt. Bafög reicht zwar oft gerade so zum Leben, doch gibt es mindestens die Hälfte der Förderung geschenkt.

from Finanztip Feed
Supported by Video Collection
Share:

U.S. appeals court says GSK cannot be sued over generic drug suicide

U.S. appeals court says GSK cannot be sued over generic drug suicide


A U.S. appeals court on Wednesday tossed a $3 million verdict against GlaxoSmithKline over the suicide of an attorney who took a generic version of the company's antidepressant Paxil, finding the company could not be held liable for injuries allegedly caused by a generic copy. A unanimous three-judge panel at the 7th U.S. Circuit Court of Appeals said claims against GSK were preempted by federal law and U.S. Supreme Court rulings.



from Biotech News
Share:

Finanzen: Sonderkündigungsrecht Strom : Sonderkündigungsrecht Strom und Gas

Wenn eine Preiserhöhung für Strom oder Gas ins Haus flattert, haben Sie ein Sonderkündigungsrecht. Sie können den Liefervertrag kündigen, ohne eine Frist beachten zu müssen.

from Finanztip Feed
Supported by Video Collection
Share:

China Censors Social Media Posts on Vaccine Scandal

China Censors Social Media Posts on Vaccine Scandal


The South China Morning Post has reported that a Chinese drug company produced nearly 500,000 substandard vaccines for babies, roughly double an earlier estimate by authorities investigating a safety scandal. China's drug regulator in July accused Changchun Changsheng Bio-technology of selling 252,600 doses of ineffective DPT vaccines to inoculate children against diphtheria, whooping cough and tetanus.



from Biotech News
Share:

Missouri judge affirms $4.69 billion talc verdict, J&J vows to appeal

Missouri judge affirms $4.69 billion talc verdict, J&J vows to appeal


FILE PHOTO: Bottles of Johnson & Johnson baby powder line a drugstore shelf in New York October 15, 2015. REUTERS/Lucas Jackson/File Photo J&J in a statement on Wednesday said it would continue to pursue all available appellate remedies.



from Biotech News
Share:

Finanzen: Kfz-Fahranfänger : Kfz-Versicherung Fahranfänger

Eine günstige Kfz-Versicherung für Fahranfänger ist selten. Mit einigen Kniffen können Sie die Beiträge für die Autoversicherung senken.

from Finanztip Feed
Supported by Video Collection
Share:

Victory Capital Management Inc. Has $5.71 Million Holdings in Novartis AG

Victory Capital Management Inc. Has $5.71 Million Holdings in Novartis AG


Victory Capital Management Inc. trimmed its position in shares of Novartis AG by 11.5% in the second quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 75,530 shares of the company's stock after selling 9,859 shares during the period.



from Biotech News
Share:

Exact Sciences surges after marketing deal with Pfizer for cancer test

Exact Sciences surges after marketing deal with Pfizer for cancer test


Exact Sciences Corp's shares shot up as much as 26 percent on Wednesday after the company said Pfizer Inc would share marketing expenses and co-promote the company's stool screening test for colorectal cancer. The companies will invest a combined $48 million, shared equally, next year to market the non-invasive DNA screening test Cologuard, Exact Sciences Chief Executive Officer Kevin Conroy told Reuters in an interview.



from Biotech News
Share:

Evotec und Novo Nordisk bilden Forschungsallianz in Diabetes und Adipositas

Evotec und Novo Nordisk bilden Forschungsallianz in Diabetes und Adipositas


Evotec AG gab die Bildung einer strategischen Allianz mit Novo Nordisk bekannt, mit dem Ziel, neue niedermolekulare Therapien zur Behandlung von Patienten mit Diabetes und Adipositas sowie damit verbundenen Folgeerkrankungen wie nichtalkoholische Steatohepatitis („NASH“), Herz-Kreislauf-Erkrankungen...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.
Share:

Chefgehälter 2018: Chemie- und Pharma gehören zu den Top-Branchen

Chefgehälter 2018: Chemie- und Pharma gehören zu den Top-Branchen


image description
Wie viel Geld verdienen Geschäftsführer? Um diese Frage zu beantworten, hat das Vergleichsportal Gehalt.de 5.121 Daten von Chefs analysiert und die Gehälter nach Branchen sowie Firmengröße ausgewertet. Das Ergebnis: Bei großen Finanzdienstleistern bekommen Geschäftsführer mit rund 340.000 Euro im Ja...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.
Share:

Banque Pictet & Cie Sa Sells 1,260 Shares of SPDR S&P Biotech Etf

Banque Pictet & Cie Sa Sells 1,260 Shares of SPDR S&P Biotech Etf


Banque Pictet & Cie SA lowered its stake in SPDR S&P Biotech ETF by 0.8% during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 152,180 shares of the exchange traded fund's stock after selling 1,260 shares during the period.



from Biotech News
Share:

Banque Pictet & Cie SA Increases Position in AmerisourceBergen Corp.

Banque Pictet & Cie SA Increases Position in AmerisourceBergen Corp.


Banque Pictet & Cie SA increased its holdings in AmerisourceBergen Corp. by 214.2% during the 2nd quarter, according to its most recent Form 13F filing with the SEC. The fund owned 120,693 shares of the company's stock after purchasing an additional 82,283 shares during the period.



from Biotech News
Share:

Inogen (INGN) Given a $258.00 Price Target at Stifel Nicolaus

Inogen (INGN) Given a $258.00 Price Target at Stifel Nicolaus


The brokerage currently has a "buy" rating on the medical technology company's stock. Stifel Nicolaus' price target would suggest a potential upside of 10.41% from the company's current price.



from Biotech News
Share:

Finanzen: Falsche Angaben : Falsche Angaben in der Kfz-Versicherung

Kunden müssen in der Kfz-Versicherung wahre Angaben etwa zu den Fahrern des Autos machen. Wer vorsätzlich schummelt, geht das Risiko einer Vertragsstrafe ein.

from Finanztip Feed
Supported by Video Collection
Share:

Opioid crisis creating drop in life expectancy among young adults in U.S. Source: Cox Media Group

Opioid crisis creating drop in life expectancy among young adults in U.S. Source: Cox Media Group


The research features findings from two separate observational studies, one pointing to the ongoing opioid crisis in the U.S. as a key contributor to recent declines, and another suggesting the declines in both the U.S. and the United Kingdom transcend the opioid epidemic among diverse populations. Only four countries included in the first study of 18 high-income nations - Australia, Japan, Denmark and Norway - showed increasing rates for both men and women in 2015.



from Biotech News
Share:

The 3 Biotech Stocks You Need in Your Portfolio

The 3 Biotech Stocks You Need in Your Portfolio


The numbers are staggering. Over the next six years, the biotech market is expected to add $593 billion in value - a 419% leap over the size of today's biotech market.



from Biotech News
Share:

Finanzen: Schönheitsreparaturen im Mietrecht : Schönheitsreparaturen

Dass der Mieter Schönheitsreparaturen durchführen muss, steht in fast allen Mietverträgen. Doch die Klauseln sind oft unwirksam.

from Finanztip Feed
Supported by Video Collection
Share:

FDA extends some EpiPen expiration dates to combat shortage

FDA extends some EpiPen expiration dates to combat shortage


This photo shows an EpiPen epinephrine auto-injector, a Mylan product, in Hendersonville, Texas. Some big pension funds are urging shareholders of EpiPen maker Mylan to reject several company directors and the compensation it gives top executives, including the nearly $100 million Chairman and former CEO Robert Coury received last year.



from Biotech News
Share:

Will GlaxoSmithKline Indien-Tochter verkaufen?

Will GlaxoSmithKline Indien-Tochter verkaufen?


(dpa-AFX) Der Pharmakonzern GlaxoSmithKline holt Kreisen zufolge Gebote für sein Geschäft mit rezeptfreien Arzneien und Nahrungsergänzungsmitteln in Indien ein. Der britische Pharmariese habe um Rückmeldung bis Mitte September gebeten, berichtete die Nachrichtenagentur Bloomberg am Dienstag unter Be...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.
Share:

Kane Biotech Announces Second Quarter 2018 Financial Results

Kane Biotech Announces Second Quarter 2018 Financial Results


Kane Biotech Inc. announces its Second Quarter 2018 Financial Results. Kane Biotech Inc. is a biotechnology company engaged in the research, development and commercialization of technologies and products that prevent and remove microbial biofilms.



from Biotech News
Share:

Dieses winzige Teilchen könnte Millionen von Leben verändern

Dieses winzige Teilchen könnte Millionen von Leben verändern


image description
Da die Nieren die Filterstoffe in unserem Körper sind, sind sie sehr daran interessiert, kleine Partikel loszuwerden, die nicht dazugehören. Und wenn die Niere ein Teilchen nicht herausfiltert und es über den Urin ausscheidet, kann es von der Leber ausgeschieden werden, die mit Hilfe von Makrophagen...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.
Share:

Neue Typ-1-Diabetes-Therapie verspricht eine langfristige Rückentwicklung

Neue Typ-1-Diabetes-Therapie verspricht eine langfristige Rückentwicklung


image description
Was wäre, wenn statt täglicher Insulininjektionen oder dem Tragen von Pumpen alle paar Monate eine Spritze für Sie - oder Ihren Hund - den Typ-1-Diabetes rückgängig machen könnte?Es könnte das Einführen gesunder Pankreaszellen wie ein trojanisches Pferd erfordern.Das trojanische Pferd wäre in diesem...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.
Share:

Warum manche Menschen mit Alzheimer-Hirnmarkern keine Demenz haben

Warum manche Menschen mit Alzheimer-Hirnmarkern keine Demenz haben


Eine neue Studie von der University of Texas Medical Branch in Galveston hat aufgedeckt, warum einige Menschen, die Hirnmarker von Alzheimer haben, nie die klassische Demenz entwickeln, wie es andere tun.Die Alzheimer-Krankheit, die häufigste Form der Demenz, betrifft mehr als 5 Millionen Amerikaner...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.
Share:

FuE-Ausgaben der Chemie- und Pharmabranche erreichen neuen Höchststand

FuE-Ausgaben der Chemie- und Pharmabranche erreichen neuen Höchststand


image description
Die deutsche chemisch-pharmazeutische Industrie wird im laufenden Jahr mit ihren Ausgaben für Forschung und Entwicklung (FuE) erstmals die 11-Milliarden-Euro-Grenze erreichen. Das prognostizierte Thomas Wessel, Vorsitzender des Ausschusses Forschung, Wissenschaft und Bildung im Verband der Chemische...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.
Share:

Researchers reverse congenital blindness in mice, study finds

Researchers reverse congenital blindness in mice, study finds


The technique takes supportive cells in the retina called Mller glia and changes them into photoreceptors, light-sensitive cells allowing people to see in low light. The study, funded by the National Institutes of Health, found that photoreceptors created with this technique developed as effectively in congenitally blind mice - those born blind - as in normal mice.



from Biotech News
Share:

MBio Diagnostics, Inc. Announces Additional $6 Million in Series B Funding

MBio Diagnostics, Inc. Announces Additional $6 Million in Series B Funding


The funding supports the refinement of the MBio platform and improvements in manufacturing as the company scales-up to support its commercialization partners. The MBio platform brings remarkable simplicity of use and speed to a broad range of test modalities, from protein arrays and nucleic acid detection to cellular analysis.



from Biotech News
Share:

China's Changchun mayor resigns after vaccine scandal - state media

China's Changchun mayor resigns after vaccine scandal - state media


The mayor of the Chinese city of Changchun resigned on Tuesday, state media reported, after a safety scandal at Changchun-based vaccine maker Changsheng Biotechnology sparked widespread consumer anger. FILE PHOTO - People gather at the gate of Changchun Changsheng Bio-technology Co Ltd, the Chinese vaccine maker, in Changchun, China July 26, 2018.



from Biotech News
Share:

Amended FCA Complaint Cannot Cure A First-to-File Violation

Amended FCA Complaint Cannot Cure A First-to-File Violation


The Second Circuit Court of Appeals recently held that a False Claims Act relator could not evade the FCA's first-to-file bar by filing an amended complaint after two earlier-filed FCA suits alleging similar conduct had been dismissed. United States ex rel.



from Biotech News
Share:

Finanzen: Baufinanzierungsrechner : Baufinanzierungsrechner

Viele träumen von den eigenen vier Wänden. Doch davor steht oft ein wenig Rechenarbeit. Unsere Rechner zur Baufinanzierung helfen Ihnen dabei.

from Finanztip Feed
Supported by Video Collection
Share:

Finanzen: Gaspreisvergleich : Gasvergleich

Mit dem Finanztip-Gasrechner finden Sie einen günstigen Tarif. Der Wechsel zum neuen Anbieter ist anschließend einfach.

from Finanztip Feed
Supported by Video Collection
Share:

Manchester Capital Management LLC Has $1.40 Million Position in Gilead Sciences, Inc.

Manchester Capital Management LLC Has $1.40 Million Position in Gilead Sciences, Inc.


Manchester Capital Management LLC boosted its stake in shares of Gilead Sciences, Inc. by 61.6% during the 2nd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 19,782 shares of the biopharmaceutical company's stock after purchasing an additional 7,541 shares during the period.



from Biotech News
Share:

Amgen, Inc. (Amgn) Shares Sold by Oakwood Capital Management LLC Ca

Amgen, Inc. (Amgn) Shares Sold by Oakwood Capital Management LLC Ca


Oakwood Capital Management LLC CA lessened its stake in shares of Amgen, Inc. by 2.3% in the second quarter, Holdings Channel reports. The institutional investor owned 30,874 shares of the medical research company's stock after selling 715 shares during the quarter.



from Biotech News
Share:

McKesson Co. (MCK) Shares Bought by Schwab Charles Investment Management Inc.

McKesson Co. (MCK) Shares Bought by Schwab Charles Investment Management Inc.


Schwab Charles Investment Management Inc. raised its stake in shares of McKesson Co. by 10.1% during the second quarter, according to its most recent filing with the Securities and Exchange Commission .



from Biotech News
Share:

Kane Biotech (KNE) Set to Announce Quarterly Earnings on Wednesday

Kane Biotech (KNE) Set to Announce Quarterly Earnings on Wednesday


Kane Biotech last announced its quarterly earnings results on Thursday, May 17th. The company reported C EPS for the quarter.



from Biotech News
Share:

Brokerages Anticipate Quest Diagnostics Inc (DGX) Will Announce Quarterly Sales of $1.95 Billion

Brokerages Anticipate Quest Diagnostics Inc (DGX) Will Announce Quarterly Sales of $1.95 Billion


Analysts forecast that Quest Diagnostics Inc will announce $1.95 billion in sales for the current quarter, according to Zacks . Eight analysts have issued estimates for Quest Diagnostics' earnings, with estimates ranging from $1.94 billion to $1.98 billion.



from Biotech News
Share:

Regeneron Pharmaceuticals Inc (REGN) Shares Bought by KBC Group NV

Regeneron Pharmaceuticals Inc (REGN) Shares Bought by KBC Group NV


KBC Group NV raised its stake in shares of Regeneron Pharmaceuticals Inc by 5.0% during the 2nd quarter, HoldingsChannel.com reports. The institutional investor owned 6,568 shares of the biopharmaceutical company's stock after buying an additional 315 shares during the period.



from Biotech News
Share:

Finanzen: Daten-Roaming : Daten-Roaming

Wenn Sie im Ausland mit dem Handy surfen, „roamen“ Sie. Während Sie innerhalb der EU keine hohen Kosten fürchten müssen, kann Daten-Roaming außerhalb Europas schnell teuer werden.

from Finanztip Feed
Supported by Video Collection
Share:

Finanzen: Roaming (Handy im Ausland) : Roaming-Gebühren

Wenn Sie im Ausland zum Handy greifen, kann es teuer werden. In der EU verhindert die Roaming-Verordnung zusätzliche Kosten. Helfen können auch Auslandsoptionen oder ausländische Sim-Karten.

from Finanztip Feed
Supported by Video Collection
Share:

Insulinhersteller Novo Nordisk kauft britisches Start-Up

Insulinhersteller Novo Nordisk kauft britisches Start-Up


(dpa-AFX) Der dänische Insulinhersteller Novo Nordisk verstärkt sein Diabetes-Geschäft mit einem Zukauf. Wie Novo Nordisk am Freitag in Kopenhagen mitteilte, übernimmt der Konzern das britische Start-Up Ziylo. Das Unternehmen erforscht und entwickelt synthetische Moleküle, die Insulin besser binden ...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.
Share:

Finanzen: Handy-Flatrates : Handy-Flatrate

Flatrates ermöglichen Mobilfunkleistungen zum Festpreis. Finanztip zeigt, welche Arten von Flatrates es gibt und ob sich die Pauschaltarife für Sie lohnen.

from Finanztip Feed
Supported by Video Collection
Share:

Amarin Co. plc (AMRN) Expected to Post Earnings of -$0.09 Per Share

Amarin Co. plc (AMRN) Expected to Post Earnings of -$0.09 Per Share


Equities research analysts expect Amarin Co. plc to report earnings per share for the current quarter, Zacks reports.



from Biotech News
Share:

Finanzen: Tarifmerkmale : Tarifmerkmale

Merkmale wie Jahresfahrleistung und Fahreralter beeinflussen den Preis einer Kfz-Versicherung mit. Wir zeigen, welche Ersparnis drin ist und wie viel sinnvoller Zusatzschutz kostet.

from Finanztip Feed
Supported by Video Collection
Share:

Finanzen: Kfz für Senioren : Alterszuschlag

Senioren sind für viele Versicherer ein Sicherheitsrisiko im Straßenverkehr. Fast alle Tarife für Autoversicherungen werden teurer, je älter der Fahrer ist.

from Finanztip Feed
Supported by Video Collection
Share:

Comparing Victory Capital

Comparing Victory Capital


Victory Capital and Cohen & Steers are both small-cap finance companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, profitability, analyst recommendations, dividends, valuation, earnings and risk. 15.9% of Victory Capital shares are owned by institutional investors.



from Biotech News
Share:

SPDR S&P Biotech Etf (Xbi) Holdings Trimmed by Boyer & Corporon Wealth Management LLC

SPDR S&P Biotech Etf (Xbi) Holdings Trimmed by Boyer & Corporon Wealth Management LLC


Boyer & Corporon Wealth Management LLC trimmed its position in shares of SPDR S&P Biotech ETF by 9.7% during the 2nd quarter, HoldingsChannel reports. The firm owned 64,434 shares of the exchange traded fund's stock after selling 6,901 shares during the quarter.



from Biotech News
Share:

What is fentanyl, the drug that pushed overdose deaths to a record high in 2017?Hello Giggles

What is fentanyl, the drug that pushed overdose deaths to a record high in 2017?Hello Giggles


A recent report from the Centers for Disease Control and Prevention found that overdose deaths hit 72,000 in 2017. But what is fentanyl, the drug responsible for pushing that number to a record high? A new report from the Centers for Disease Control and Prevention paints a grim picture of the opioid crisis facing the United States.



from Biotech News
Share:

Give pregnant mothers an update.

Give pregnant mothers an update.


With an uptick in news about food-poisoning outbreaks, pregnant women need to be aware of which foods carry certain risks. With an uptick in news about food-poisoning outbreaks, pregnant women need to be aware of which foods carry certain risks.



from Biotech News
Share:

Maine sixth worst state for increase in overdose deaths

Maine sixth worst state for increase in overdose deaths


Data from the U.S. Centers for Disease Control and Prevention shows Maine is the sixth worst state when it comes to an increase in overdose deaths. According to the CDC, overdose deaths increased 10.9 percent between January 2017 and 2018 compared to the national average of 6.6 percent.



from Biotech News
Share:

Somewhat Favorable Press Coverage Somewhat Unlikely to Impact Fortress Biotech (FBIO) Share Price

Somewhat Favorable Press Coverage Somewhat Unlikely to Impact Fortress Biotech (FBIO) Share Price


Media headlines about Fortress Biotech have trended somewhat positive this week, Accern Sentiment reports. The research group scores the sentiment of press coverage by reviewing more than 20 million news and blog sources.



from Biotech News
Share:

Utah's overdose deaths fall 12 percent despite nationwide surge

Utah's overdose deaths fall 12 percent despite nationwide surge


Defying a worrisome national trend, Utah recently recorded the nation's second-largest drop in drug overdose deaths in estimates from the Centers for Disease Control and Prevention. The day after related data was first reported , officials in Utah expressed cautious optimism about a 12 percent decline in fatal overdoses over a one-year period ending January 2018.



from Biotech News
Share:

Research Analysts' Weekly Ratings Changes for Perrigo

Research Analysts' Weekly Ratings Changes for Perrigo


They now have a "buy" rating on the stock. 8/10/2018 - Perrigo had its price target lowered by analysts at JPMorgan Chase & Co.



from Biotech News
Share:

BioSpecifics Technologies Corp. (BSTC) Major Shareholder Of Edwin H. Wegman Estate Sells 3,100 Shares

BioSpecifics Technologies Corp. (BSTC) Major Shareholder Of Edwin H. Wegman Estate Sells 3,100 Shares


BioSpecifics Technologies Corp. major shareholder Of Edwin H. Wegman Estate sold 3,100 shares of the company's stock in a transaction on Saturday, September 15th. The shares were sold at an average price of $41.21, for a total transaction of $127,751.00.



from Biotech News
Share:

-$0.14 Earnings Per Share Expected for Moleculin Biotech Inc (MBRX) This Quarter

-$0.14 Earnings Per Share Expected for Moleculin Biotech Inc (MBRX) This Quarter


Brokerages expect Moleculin Biotech Inc to announce earnings per share for the current fiscal quarter, Zacks Investment Research reports. Zero analysts have made estimates for Moleculin Biotech's earnings.



from Biotech News
Share:

FDA approves Bristol-Myers' Opdivo for small cell lung cancer

FDA approves Bristol-Myers' Opdivo for small cell lung cancer


Bristol-Myers Squibb Co said on Friday the U.S. Food and Drug Administration approved its treatment, Opdivo, for patients whose lung cancer had progressed even after undergoing chemotherapy and at least one other therapy. FILE PHOTO: Logo of global biopharmaceutical company Bristol-Myers Squibb is pictured on the blouse of an employee in Le Passage, near Agen, France, March 29, 2018.



from Biotech News
Share:

Drug overdose deaths up nearly 7% in US

Drug overdose deaths up nearly 7% in US


The CDC projects some 49,000 people will have died from opioid overdoses in 2017 once the counting is done. ATLANTA Drug overdoses killed more than 72,000 Americans in 2017, up 6.6 percent from the year before, according to estimates from the Centers for Disease Control and Prevention .



from Biotech News
Share:

EpiPen shortage raises alarm for parents as kids head back to school

EpiPen shortage raises alarm for parents as kids head back to school


Jim Davis, a parent of an 8-year-old daughter who has a peanut allergy, was startled to learn that his Walgreens pharmacy did not have a single EpiPen available for her and wouldn't have them in stock until well after school began. The family keeps a stock of at least six injectors between home and school.



from Biotech News
Share:

Death rate from liver cancer skyrockets

Death rate from liver cancer skyrockets


SARASOTA, FL - Startling statistics have been released by the Centers for Disease Control and Prevention. They show death rates from liver cancer have climbed 43% since 2000.



from Biotech News
Share:

Amgen, Inc. (AMGN) Stake Lowered by Tirschwell & Loewy Inc.

Amgen, Inc. (AMGN) Stake Lowered by Tirschwell & Loewy Inc.


Tirschwell & Loewy Inc. trimmed its position in shares of Amgen, Inc. by 0.8% during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission . The firm owned 76,445 shares of the medical research company's stock after selling 579 shares during the period.



from Biotech News
Share:

UPDATE 2-Japan's Eisai sets price tag of about $16,000 on liver cancer drug

UPDATE 2-Japan's Eisai sets price tag of about $16,000 on liver cancer drug


Japan's Eisai Co Ltd said on Thursday it would price its cancer drug Lenvima at about $16,000 for a month's supply before discounts, after the U.S. Food and Drug Administration approved its use in patients with a common form of liver cancer. The drug was approved as the first therapy in over a decade in the United States to treat previously untreated patients with an advanced or intermediate stage of unresectable hepatocellular carcinoma .



from Biotech News
Share:

Finanzen: Kündigungsdienste : Kündigungsdienste im Vergleich

Wer Verträge einfach laufen lässt, verschenkt Geld. Mit einem Kündigungsservice werden Sie unliebsame Verträge schnell los.

from Finanztip Feed
Supported by Video Collection
Share:

FDA approves first generic EpiPen competitor Source: Cox Media Group

FDA approves first generic EpiPen competitor Source: Cox Media Group


Today's approval of the first generic version of the most-widely prescribed epinephrine auto-injector in the U.S. is part of our commitment to making lower cost, safe, and effective generic alternatives available to patients. https://t.co/D2xkAYFKKQ The new drug, from Teva Pharmaceuticals USA, can now automatically be substituted at the pharmacy counter for EpiPen and EpiPen Jr. prescriptions, The Washington Post reported .



from Biotech News
Share:

Brandenburg verspricht Aufklärung im Pharmaskandal

Brandenburg verspricht Aufklärung im Pharmaskandal


(dpa) Im Skandal um den Handel mit gestohlenen Krebsmedikamenten hat Brandenburgs Regierungschef Dietmar Woidke eine umfassende Aufklärung zugesagt. Es müsse geklärt werden, was bei der Aufsicht und Kontrolle schief gelaufen sei, sagte der SPD-Politiker am Donnerstag in einer erneuten Sondersitzung ...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.
Share:

The Billionaires and The Guru: How a Family Burned Through $2 Billion

The Billionaires and The Guru: How a Family Burned Through $2 Billion


Along the river Beas in North India sits a sprawling spiritual commune that's somewhere between a traditional ashram and a Florida gated community. There's a grand meeting hall with tiered spires and pearl domes, but also tract housing and an American-style supermarket.



from Biotech News
Share:

Mit Licht modifizierte Bakterien als Schlüssel für zukünftige Lab-on-a-Chip Anwendungen

Mit Licht modifizierte Bakterien als Schlüssel für zukünftige Lab-on-a-Chip Anwendungen


image description
Wissenschaftler haben Lichtmuster verwendet, um die Schwimmgeschwindigkeit von Bakterien zu kontrollieren und sie in verschiedene Formen zu lenken. Eine solche Kontrolle der Bakterien ermöglicht es, sie als Mikrobausteine für die nächste Generation mikroskopischer Geräte zu verwenden. Zum Beispiel k...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.
Share:

Mit Licht erzeugte Polymere zur Bakterienbekämpfung

Mit Licht erzeugte Polymere zur Bakterienbekämpfung


Forscher des Department of Chemistry und der Warwick Medical School haben einen Weg entwickelt, um große Polymerbibliotheken so zu synthetisieren, dass ihr Screening auf antimikrobielle Aktivität schneller und ohne die Notwendigkeit, versiegelte Vials zu verwenden, erfolgt.Durch die Verwendung mehre...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.
Share:

Germany's Bayer says it can start integrating Monsanto

Germany's Bayer says it can start integrating Monsanto


German pharmaceutical company Bayer AG says it can now start integrating U.S. seed and weed-killer maker Monsanto Co. after completing the required sale of some of its crop science business.



from Biotech News
Share:

New ETF allows you to invest in up-and-coming Chinese biotech companies

New ETF allows you to invest in up-and-coming Chinese biotech companies


Investors now have a way to buy into and track the up-and-coming Chinese biotechnology sector, through a new exchange-traded fund that launched on Wednesday. The sector is at a unique, even revolutionary, moment in time: already developing world-class, cutting-edge therapeutics in areas like oncology and gene therapy, and getting a boost from a variety of new policies and regulatory factors, Loncar says.



from Biotech News
Share:

Pfizer bets on biotech flu vaccine in $425 mln BioNTech alliance

Pfizer bets on biotech flu vaccine in $425 mln BioNTech alliance


Pfizer has agreed to pay German biotech firm BioNTech up to $425 million in an alliance to develop more effective influenza jabs, the latest among several major pharma companies to bank on a promising new genetic approach. FILE PHOTO: The Pfizer logo is seen at their world headquarters in New York April 28, 2014.



from Biotech News
Share:

Pfizer Inc. (PFE) Stake Decreased by Uniplan Investment Counsel Inc.

Pfizer Inc. (PFE) Stake Decreased by Uniplan Investment Counsel Inc.


Uniplan Investment Counsel Inc. reduced its holdings in Pfizer Inc. by 38.9% during the first quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 356,161 shares of the biopharmaceutical company's stock after selling 227,208 shares during the quarter.



from Biotech News
Share:

Measles outbreak hits 21 states

Measles outbreak hits 21 states


ATLANTA The Centers for Disease Control and Prevention says 107 people from 21 states have come down with measles through July 14 of this year. Cases have been reported in Arkansas, California, Connecticut, Florida, Illinois, Indiana, Kansas, Louisiana, Maryland, Michigan, Missouri, Nevada, New Jersey, New York, North Carolina, Oklahoma, Oregon, Pennsylvania, Tennessee, Texas, and Washington and the District of Colombia.



from Biotech News
Share:

Finanzen: Bankenvergleich : Bankenvergleich

Mit dem Bankenvergleich von Finanztip finden Sie eine Bank, die Girokonto, Kreditkarte und Wertpapierdepot mit guten Konditionen anbietet.

from Finanztip Feed
Supported by Video Collection
Share:

Express Scripts staking out million dollar gene therapies

Express Scripts staking out million dollar gene therapies


Now it is quietly building a side business: getting paid to help drug companies dispense a new generation of high-priced drugs. FILE PHOTO: Express Scripts Chief Medical Officer Steve Miller poses for a portrait in the Manhattan borough of New York January 22, 2015.



from Biotech News
Share:

Infections from a dog lick are a risk but very rare. Experts say get medical help fast.

Infections from a dog lick are a risk but very rare. Experts say get medical help fast.


The recent reports of death and serious injury to two Wisconsin residents tied to bacteria in dogs' saliva is no reason to panic, McQuiston said. "I have two dogs and they play and lick my children every day, and I am not concerned about capnocytophaga, " said McQuiston, deputy director of the Division of High-Consequence Pathogens and Pathology with the federal Centers for Disease Control and Prevention in Atlanta.



from Biotech News
Share:

Vaccine scandal: number of substandard doses doubles to 500,000

Vaccine scandal: number of substandard doses doubles to 500,000


A Chinese drug company produced nearly 500,000 substandard vaccines for babies, roughly double an earlier estimate by authorities investigating a safety scandal, Xinhua reported on Wednesday. China's drug regulator in July accused Changchun Changsheng Bio-technology of selling 252,600 doses of ineffective DPT vaccines to inoculate children against diphtheria, whooping cough and tetanus.



from Biotech News
Share:

Long-acting injection a shot in the arm for GSK's HIV business

Long-acting injection a shot in the arm for GSK's HIV business


A long-acting injection developed by GlaxoSmithKline and given once a month has proved as effective as standard daily pills for controlling the AIDS virus, lifting prospects for the British drugmaker's key HIV business. GSK's majority-owned ViiV Healthcare unit said on Wednesday the experimental two-drug injection of cabotegravir and rilpivirine maintained similar rates of viral suppression compared with a standard three-drug oral regimen, after 48 weeks of a clinical trial.



from Biotech News
Share:

Boy, eight, urges company to lower price of cystic fibrosis drug

Boy, eight, urges company to lower price of cystic fibrosis drug


An eight-year-old boy with cystic fibrosis has urged a pharmaceutical company to lower the price of a drug so it can be made available on the NHS. Orkambi received its European licence exactly 1,000 days ago, but the National Institute of Care and Excellence has not recommended it for use on grounds of cost-effectiveness.



from Biotech News
Share:

Finanzen: Amazon-Visa-Karte : Amazon Kreditkarte

Mit der Amazon-Kreditkarte sammeln Sie Punkte beim Bezahlen. Die können Sie wieder zum Einkaufen benutzen. Die Karte ist aber teuer.

from Finanztip Feed
Supported by Video Collection
Share:

Finanzen: Advanzia Mastercard Gold – nur für gut Organisierte : Advanzia Mastercard Gold

Null Euro Jahresgebühr, aber ein ziemlich hoher Sollzins. Wir zeigen weitere Stärken und Schwächen der Karte.

from Finanztip Feed
Supported by Video Collection
Share:

Your child is nervous about the new school year, which may be normal - or not

Your child is nervous about the new school year, which may be normal - or not


More than 2 million American children have been diagnosed with anxiety disorders, including 3.5 percent of those between ages 6 and 11, says Walkup, who was part of a new study with researchers from the Centers for Disease Control and Prevention. More than 2 million American children have been diagnosed with anxiety disorders, including 3.5 percent of those between ages 6 and 11, says Walkup, who was part of a new study with researchers from the Centers for Disease Control and Prevention.



from Biotech News
Share:

Moleculin Biotech (MBRX) Releases Earnings Results, Misses Expectations By $0.06 EPS

Moleculin Biotech (MBRX) Releases Earnings Results, Misses Expectations By $0.06 EPS


Moleculin Biotech issued its earnings results on Monday. The company reported earnings per share for the quarter, missing the Zacks' consensus estimate of by , MarketWatch Earnings reports.



from Biotech News
Share:

Heska Corp (HSKA) EVP Steven M. Eyl Sells 1,051 Shares of Stock

Heska Corp (HSKA) EVP Steven M. Eyl Sells 1,051 Shares of Stock


Heska Corp EVP Steven M. Eyl sold 1,051 shares of Heska stock in a transaction dated Friday, August 10th. The shares were sold at an average price of $98.00, for a total transaction of $102,998.00.



from Biotech News
Share:

Altfest L J & Co. Inc. Reduces Holdings in SPDR S&P Biotech Etf

Altfest L J & Co. Inc. Reduces Holdings in SPDR S&P Biotech Etf


Altfest L J & Co. Inc. lowered its stake in SPDR S&P Biotech ETF by 18.1% during the 2nd quarter, according to its most recent Form 13F filing with the SEC.



from Biotech News
Share:

Head to Head Survey: Natural Health Trends

Head to Head Survey: Natural Health Trends


Natural Health Trends and Central Garden & Pet are both consumer discretionary companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, valuation, profitability, earnings, dividends, analyst recommendations and institutional ownership. This table compares Natural Health Trends and Central Garden & Pet's net margins, return on equity and return on assets.



from Biotech News
Share:

Cutera (CUTR) versus Aradigm (ARDM) Head to Head Analysis

Cutera (CUTR) versus Aradigm (ARDM) Head to Head Analysis


Cutera and Aradigm are both small-cap computer and technology companies, but which is the superior stock? We will contrast the two businesses based on the strength of their institutional ownership, valuation, analyst recommendations, dividends, earnings, risk and profitability. 95.8% of Cutera shares are held by institutional investors.



from Biotech News
Share:

Press release distribution, EDGAR filing, XBRL, regulatory filings

Press release distribution, EDGAR filing, XBRL, regulatory filings


Total revenues for the three-month period ended June 30, 2... )--Veritone, Inc. , a leading provider of artificial intelligence technology and solutions, today reported results for the second quarter ended ... )--Medallion Financial Corp. , a commercial finance company that originates and services loans in various niche industries, announced today its 2018 second quar... )--E*TRADE Financial Corporate Services, Inc. recently hosted Directions, its annual equity compensation conference, during which attendees unpacked core challenges facing t... )--The "Affluent Insights 2017-18: China Luxury Report" report has been added to ResearchAndMarkets.com's offering.



from Biotech News
Share:

Nigerian Biotech Startup Using Shrimp Shells To Save Food Wins Top Prize

Nigerian Biotech Startup Using Shrimp Shells To Save Food Wins Top Prize


In Nigeria, the aquaculture industry makes up a significant portion of the nation's industry. With over 100,000 metric tons of fish being produced annually, the industry creates both wealth for the economy, and a sizeable amount of shrimp shell waste.



from Biotech News
Share:

Email reveals former Salk president's efforts to discourage gender discrimination suit

Email reveals former Salk president's efforts to discourage gender discrimination suit


The former president of the Salk Institute discouraged one of her professors from suing for gender discrimination, saying in a private email that legal action could damage the La Jolla science center's reputation - and suggested it might harm the researcher's career. "Families have disagreements.



from Biotech News
Share:

Court Denies J&J's Motion to Dismiss Pfizer's Complaint in Antitrust Suit

Court Denies J&J's Motion to Dismiss Pfizer's Complaint in Antitrust Suit


As we reported here , Pfizer filed an antitrust lawsuit last year against Johnson & Johnson in the U.S. District Court for the Eastern District of Pennsylvania alleging that J&J has engaged in an anticompetitive scheme to protect its Remicade product since Pfizer introduced its competing biosimilar Inflectra in 2016. As we reported here , on November 18, 2017, J&J filed a motion to dismiss Pfizer's complaint and on January 26, 2018, the Biosimilars Council filed an unopposed motion for leave to file an amicus curiae brief in opposition to J&J's motion to dismiss.



from Biotech News
Share:

Global Orphan Drugs Market Analysis & Outlook 2018-2022 - Key Players are Roche Holding, Novartis International, Bristol-Myers Squibb and Celgene Corp - ResearchAndMarkets.com

Global Orphan Drugs Market Analysis & Outlook 2018-2022 - Key Players are Roche Holding, Novartis International, Bristol-Myers Squibb and Celgene Corp - ResearchAndMarkets.com


Global Orphan Drugs Market Analysis & Outlook 2018-2022 - Key Players are Roche Holding, Novartis International, Bristol-Myers Squibb and Celgene Corp - ResearchAndMarkets.com Global Orphan Drugs Market: Industry Analysis & Outlook provides an extensive research and detailed analysis of the present market along with future outlook. The report discusses the major growth drivers and challenges of the market, covering the US, Europe and Asia along with the global market.



from Biotech News
Share:

UF Innovate | Sid Martin Biotech Resident Company Lacerta Therapeutics, Inc. Closes On $30 million Investment Round

UF Innovate | Sid Martin Biotech Resident Company Lacerta Therapeutics, Inc. Closes On $30 million Investment Round


Sid Martin Biotech , the leading biotechnology incubator at the University of Florida, announces resident company Lacerta Therapeutics, Inc ., has closed on a $30 million investment round. Lacerta is a clinical-stage gene therapy company using a constellation of proprietary adeno-associated virus vector technologies to develop treatments for central nervous system and lysosomal storage diseases.



from Biotech News
Share:

Orchard raises US$150 million to expand after GSK gene therapy deal

Orchard raises US$150 million to expand after GSK gene therapy deal


Anglo-American biotech company Orchard Therapeutics has raised a further US$150 million to fund its work in gene therapy, building on earlier fundraisings worth more than US$140 million. LONDON: Anglo-American biotech company Orchard Therapeutics has raised a further US$150 million to fund its work in gene therapy, building on earlier fundraisings worth more than US$140 million.



from Biotech News
Share:

Bayer's Monsanto hit by $289 million verdict

Bayer's Monsanto hit by $289 million verdict


A jury has ordered Monsanto Co. to pay $289.2 million in a landmark lawsuit over whether exposure to two of its powerful weed killers caused cancer.



from Biotech News
Share:

Finanzen: Krankenzusatzversicherungen Überblick : Krankenzusatzversicherung

Krankenzusatzversicherungen ergänzen die Leistungen der gesetzlichen Krankenkassen. Welche Policen sinnvoll sind.

from Finanztip Feed
Supported by Video Collection
Share:

Many schools still not fully prepared for disasters

Many schools still not fully prepared for disasters


Many U.S. public school districts lack comprehensive plans for responding to natural disasters, infectious disease outbreaks and other emergencies despite a federal initiative for all schools to address these needs by 2020, researchers say. Overall, roughly four out of five school districts have plans for helping students and staff with special needs during an emergency situation, the study by the U.S. Centers for Disease Control and Prevention found.



from Biotech News
Share:

Endo International PLC to Post Q3 2018 Earnings of $0.52 Per Share,...

Endo International PLC to Post Q3 2018 Earnings of $0.52 Per Share,...


Endo International PLC - Equities research analysts at Piper Jaffray Companies cut their Q3 2018 earnings per share estimates for Endo International in a research note issued on Wednesday, August 8th. Piper Jaffray Companies analyst D. Amsellem now expects that the company will earn $0.52 per share for the quarter, down from their previous estimate of $0.53.



from Biotech News
Share:

Progenics Pharmaceuticals (Part II): Explicating The Ramifications Of The Azedra Approval

Progenics Pharmaceuticals (Part II): Explicating The Ramifications Of The Azedra Approval


Progenics is an intriguing bioscience approaching its "growth inflection." As prognosticated, the company recently gained an FDA approval for its lead molecule, Azedra.



from Biotech News
Share:

Finanzen: Vorsorgeaufwendungen : Vorsorgeaufwendungen

Ihre Beiträge für die Altersvorsorge und für die Krankenversicherung können Sie als Sonderausgaben von der Steuer absetzen.

from Finanztip Feed
Supported by Video Collection
Share:

Somewhat Favorable Press Coverage Somewhat Unlikely to Impact CTI BioPharma (CTIC) Share Price

Somewhat Favorable Press Coverage Somewhat Unlikely to Impact CTI BioPharma (CTIC) Share Price


Press coverage about CTI BioPharma has trended somewhat positive on Sunday, Accern reports. The research group scores the sentiment of press coverage by analyzing more than 20 million blog and news sources in real-time.



from Biotech News
Share:

Vertex Pharmaceuticals Incorporated (VRTX) Shares Sold by Nomura Asset Management Co. Ltd.

Vertex Pharmaceuticals Incorporated (VRTX) Shares Sold by Nomura Asset Management Co. Ltd.


Nomura Asset Management Co. Ltd. lowered its stake in shares of Vertex Pharmaceuticals Incorporated by 2.5% in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission .



from Biotech News
Share:

Eli Lilly And Co (LLY) Shares Sold by Teacher Retirement System of Texas

Eli Lilly And Co (LLY) Shares Sold by Teacher Retirement System of Texas


Teacher Retirement System of Texas cut its stake in shares of Eli Lilly And Co by 20.0% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission . The fund owned 506,669 shares of the company's stock after selling 126,734 shares during the quarter.



from Biotech News
Share:

Adell Harriman & Carpenter Inc. Trims Stake in Biogen Inc

Adell Harriman & Carpenter Inc. Trims Stake in Biogen Inc


Adell Harriman & Carpenter Inc. trimmed its position in Biogen Inc by 20.2% during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 4,926 shares of the biotechnology company's stock after selling 1,245 shares during the quarter.



from Biotech News
Share:

Amgen, Inc. (AMGN) Shares Bought by Fiduciary Group LLC

Amgen, Inc. (AMGN) Shares Bought by Fiduciary Group LLC


Fiduciary Group LLC lifted its holdings in shares of Amgen, Inc. by 1.5% during the 2nd quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 20,118 shares of the medical research company's stock after acquiring an additional 303 shares during the period.



from Biotech News
Share:

Fortress Biotech (FBIO) Upgraded to Hold at Zacks Investment Research

Fortress Biotech (FBIO) Upgraded to Hold at Zacks Investment Research


According to Zacks, "Fortress Biotech, Inc. is a biopharmaceutical company. The company is engaged in acquiring, developing and commercializing novel pharmaceutical and biotechnology products.



from Biotech News
Share:

Cohen & Steers (CNS) versus Victory Capital (VCTR) Critical Comparison

Cohen & Steers (CNS) versus Victory Capital (VCTR) Critical Comparison


Cohen & Steers and Victory Capital are both small-cap finance companies, but which is the superior business? We will contrast the two companies based on the strength of their risk, dividends, profitability, analyst recommendations, valuation, institutional ownership and earnings. This is a breakdown of current recommendations and price targets for Cohen & Steers and Victory Capital, as reported by MarketBeat.



from Biotech News
Share:

Boston Common Asset Management LLC Sells 1,379 Shares of Biogen Inc

Boston Common Asset Management LLC Sells 1,379 Shares of Biogen Inc


Boston Common Asset Management LLC decreased its holdings in shares of Biogen Inc by 5.4% in the 2nd quarter, according to its most recent Form 13F filing with the SEC. The firm owned 24,167 shares of the biotechnology company's stock after selling 1,379 shares during the period.



from Biotech News
Share:

BIO-TECHNE Corp (TECH) Position Trimmed by BNP Paribas Arbitrage SA

BIO-TECHNE Corp (TECH) Position Trimmed by BNP Paribas Arbitrage SA


BNP Paribas Arbitrage SA reduced its position in BIO-TECHNE Corp by 25.8% during the second quarter, according to its most recent filing with the Securities and Exchange Commission . The firm owned 7,228 shares of the biotechnology company's stock after selling 2,515 shares during the quarter.



from Biotech News
Share:

Pfizer Inc. (PFE) Stake Boosted by BB&T Securities LLC

Pfizer Inc. (PFE) Stake Boosted by BB&T Securities LLC


BB&T Securities LLC grew its stake in shares of Pfizer Inc. by 1.6% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission . The institutional investor owned 2,182,432 shares of the biopharmaceutical company's stock after acquiring an additional 33,973 shares during the quarter.



from Biotech News
Share:

Commonwealth of Pennsylvania Public School Empls Retrmt SYS Acquires...

Commonwealth of Pennsylvania Public School Empls Retrmt SYS Acquires...


Commonwealth of Pennsylvania Public School Empls Retrmt SYS acquired a new stake in Illumina, Inc. in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission . The fund acquired 15,388 shares of the life sciences company's stock, valued at approximately $4,298,000.



from Biotech News
Share:

Agenus (AGEN) Receives News Impact Rating of 0.14

Agenus (AGEN) Receives News Impact Rating of 0.14


Media stories about Agenus have been trending somewhat positive recently, according to Accern Sentiment. Accern scores the sentiment of press coverage by reviewing more than twenty million news and blog sources in real time.



from Biotech News
Share:

Zacks: Analysts Anticipate Five Prime Therapeutics Inc (FPRX) Will Post Earnings of -$1.31 Per Share

Zacks: Analysts Anticipate Five Prime Therapeutics Inc (FPRX) Will Post Earnings of -$1.31 Per Share


Wall Street analysts expect that Five Prime Therapeutics Inc will post earnings per share for the current fiscal quarter, according to Zacks Investment Research . Three analysts have provided estimates for Five Prime Therapeutics' earnings, with the highest EPS estimate coming in at and the lowest estimate coming in at .



from Biotech News
Share:

Johnson & Johnson (JNJ) Shares Sold by Lucia Wealth Services LLC

Johnson & Johnson (JNJ) Shares Sold by Lucia Wealth Services LLC


Lucia Wealth Services LLC lowered its position in Johnson & Johnson by 10.9% in the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 97,009 shares of the company's stock after selling 11,856 shares during the quarter.



from Biotech News
Share:

Edwards Lifesciences Corp (EW) Shares Sold by Victory Capital Management Inc.

Edwards Lifesciences Corp (EW) Shares Sold by Victory Capital Management Inc.


Victory Capital Management Inc. lessened its stake in shares of Edwards Lifesciences Corp by 3.3% during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 352,520 shares of the medical research company's stock after selling 11,989 shares during the period.



from Biotech News
Share:

Zacks: Moleculin Biotech Inc (MBRX) Given Average Recommendation of...

Zacks: Moleculin Biotech Inc (MBRX) Given Average Recommendation of...


Moleculin Biotech Inc has earned an average broker rating score of 1.00 from the one analysts that provide coverage for the stock, Zacks Investment Research reports. One equities research analyst has rated the stock with a strong buy recommendation.



from Biotech News
Share:

Connecticut resident sickened in illness linked to...

Connecticut resident sickened in illness linked to...


The U.S. Centers for Disease Control and Prevention map showing states where people who reportedly consumed salads from McDonaldA's and were infected with Cyclospora, by state of residence, as of August 9, 2018. less The U.S. Centers for Disease Control and Prevention map showing states where people who reportedly consumed salads from McDonaldA's and were infected with Cyclospora, by state of residence, as of August 9, ... more At least 436 people became ill after eating salads from McDonald's restaurants, including a Connecticut resident, and the chain has pulled the lettuce blend from 3,000 of its sites, according to press releases and multiple news reports .



from Biotech News
Share:

Bristol-Myers Squibb Co (BMY) Shares Bought by Spinnaker Trust

Bristol-Myers Squibb Co (BMY) Shares Bought by Spinnaker Trust


Spinnaker Trust raised its holdings in Bristol-Myers Squibb Co by 10.7% during the second quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 44,999 shares of the biopharmaceutical company's stock after buying an additional 4,365 shares during the quarter.



from Biotech News
Share:

Sinovac Biotech Ltd. (SVA) Shares Sold by Eqis Capital Management Inc.

Sinovac Biotech Ltd. (SVA) Shares Sold by Eqis Capital Management Inc.


Eqis Capital Management Inc. lessened its position in Sinovac Biotech Ltd. by 73.7% during the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 41,828 shares of the biopharmaceutical company's stock after selling 117,165 shares during the quarter.



from Biotech News
Share:

Monsanto ordered to pay US$289 million in weedkiller cancer trial

Monsanto ordered to pay US$289 million in weedkiller cancer trial


A California jury on Friday found Monsanto liable in a lawsuit filed by a man who alleged the company's glyphosate-based weedkillers, including Roundup, caused his cancer and ordered the company to pay $289 million in damages. The case of school groundsman Dewayne Johnson was the first lawsuit to go to trial alleging glyphosate causes cancer.



from Biotech News
Share:

The mysterious case of Alberta's rogue GMO wheat

The mysterious case of Alberta's rogue GMO wheat


Prairie farmers breathed a collective sigh of relief last week, when Japan - Canada's second-largest buyer of wheat - lifted a month-long import ban imposed in the aftermath of the discovery of a few stalks of genetically modified wheat growing in a ditch in southern Alberta. Prairie farmers breathed a collective sigh of relief last week, when Japan - Canada's second-largest buyer of wheat - lifted a month-long import ban imposed in the aftermath of the discovery of a few stalks of genetically modified wheat growing in a ditch in southern Alberta.



from Biotech News
Share:

Alnylam's gene silencing drug wins FDA approval

Alnylam's gene silencing drug wins FDA approval


Alnylam Pharmaceuticals Inc's drug for a rare hereditary disease won U.S. regulatory approval on Friday, becoming the first approved treatment from a new class of medicines that use gene silencing technology. Alnylam's patisiran, commercially named Onpattro, was approved to treat polyneuropathy in patients with hereditary ATTR amyloidosis, a potentially fatal condition that affects an estimated 50,000 people worldwide.



from Biotech News
Share:

Enmeshed in the opioid epidemic, AmerisourceBergen seeks good will through its foundation

Enmeshed in the opioid epidemic, AmerisourceBergen seeks good will through its foundation


Steven Collis, right, chairman, president, and CEO of AmerisourceBergen Corp., testifies with other distributor executives during a congressional hearing about combating the opioid epidemic, on Capitol Hill, Tuesday, May 8, 2018. Police can easily tick through the tactics that people use to steal painkillers in Gaston County, N.C.: Pick through garbage, target an elderly person's home, or visit a real estate open-house, just to find prescription drugs.



from Biotech News
Share:

Life Sciences Patent Attorney Walter Wu, M.D. Joins Dorsey in Palo Alto

Life Sciences Patent Attorney Walter Wu, M.D. Joins Dorsey in Palo Alto


Aug 10, 2018--International law firm Dorsey & Whitney LLP announced today that Walter Wu, M.D., has joined the Firm's Patent Group in Palo Alto, California, as a Partner. Dr. Wu specializes in patent prosecution and portfolio strategy for emerging companies in the life sciences, and patent due diligence for life science investors.



from Biotech News
Share:

Johnson & Johnson (JNJ) Holdings Trimmed by Peapack Gladstone Financial Corp

Johnson & Johnson (JNJ) Holdings Trimmed by Peapack Gladstone Financial Corp


Peapack Gladstone Financial Corp lessened its holdings in shares of Johnson & Johnson by 0.8% in the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 262,297 shares of the company's stock after selling 2,029 shares during the quarter.



from Biotech News
Share:

New approach identifies genes that help microbes to survive in the human gut

New approach identifies genes that help microbes to survive in the human gut


Trillions of tiny microbes and bacteria live in your gut, each with their own set of genes. These gut microbes can have both beneficial and harmful effects on your health, from protecting you against inflammation to causing life-threatening infections.



from Biotech News
Share:

Shark spotted eating a sea lion off La Jolla shores

Shark spotted eating a sea lion off La Jolla shores


SAN DIEGO Cellphone video captured by a helicopter pilot on Wednesday shows a shark snacking on a sea lion in the waters off La Jolla shores not far from swimmers and kayakers. Student pilot Asher Burke said he and his instructor saw a red blotch of water.



from Biotech News
Share:

EPIX 4K Ultra HD Movies Available Now on DISH and T-Mobile's Layer3 TV

EPIX 4K Ultra HD Movies Available Now on DISH and T-Mobile's Layer3 TV


Aug 9, 2018--Premium television network EPIX announced today that DISH and Layer3 TV, a T-Mobile Company, are its first partners to roll out EPIX's new 4K Ultra HD offering. Now, EPIX subscribers on DISH and Layer3 TV will have access to a VOD package of 4K Ultra HD content directly on their set-top boxes.



from Biotech News
Share:

Finanzen: Autokreditrechner : Autofinanzierungsrechner

Die Finanzierung des neuen Wagens über das Autohaus muss nicht die günstigste Möglichkeit sein. Oft ist es besser, sich separat einen Bankkredit zu besorgen und beim Autohändler als Barzahler aufzutreten. Die optimale Möglichkeit erhalten Sie über den Finanztip-Autokreditrechner.

from Finanztip Feed
Supported by Video Collection
Share:

AmerisourceBergen Corp. (ABC) Stake Raised by Sumitomo Mitsui Trust Holdings Inc.

AmerisourceBergen Corp. (ABC) Stake Raised by Sumitomo Mitsui Trust Holdings Inc.


Sumitomo Mitsui Trust Holdings Inc. boosted its position in shares of AmerisourceBergen Corp. by 8.8% during the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 521,395 shares of the company's stock after purchasing an additional 42,329 shares during the quarter.



from Biotech News
Share:

Arzneihersteller Stada steigert Gewinn deutlich

Arzneihersteller Stada steigert Gewinn deutlich


(dpa) Eine solide Nachfrage nach Arzneien, höhere Margen und niedrigere Steuern nach der Übernahme durch Finanzinvestoren haben dem Pharmakonzern Stada mehr Gewinn gebracht. Im zweiten Quartal sank der Umsatz mit gut 579 Millionen Euro gemessen am Vorjahreszeitraum zwar leicht. Indes wurden Erlöse a...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.
Share:

Emergent Biosolutions Inc (EBS) Stake Increased by Principal Financial Group Inc.

Emergent Biosolutions Inc (EBS) Stake Increased by Principal Financial Group Inc.


Principal Financial Group Inc. lifted its stake in shares of Emergent Biosolutions Inc by 2.6% in the 1st quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 292,075 shares of the biopharmaceutical company's stock after acquiring an additional 7,367 shares during the quarter.



from Biotech News
Share:

GlaxoSmithKline plc (GSK) Given Average Rating of "Hold" by Analysts

GlaxoSmithKline plc (GSK) Given Average Rating of "Hold" by Analysts


GlaxoSmithKline plc has received an average rating of "Hold" from the twenty-four brokerages that are currently covering the firm, MarketBeat reports. One investment analyst has rated the stock with a sell recommendation, thirteen have given a hold recommendation and ten have assigned a buy recommendation to the company.



from Biotech News
Share:

Commonwealth of Pennsylvania Public School Empls Retrmt SYS Acquires...

Commonwealth of Pennsylvania Public School Empls Retrmt SYS Acquires...


Commonwealth of Pennsylvania Public School Empls Retrmt SYS acquired a new position in shares of Shire PLC in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission . The fund acquired 51,000 shares of the biopharmaceutical company's stock, valued at approximately $8,609,000.



from Biotech News
Share:

Concerns over Trump's 'man on the Hill' links to Aussie biotech ignored

Concerns over Trump's 'man on the Hill' links to Aussie biotech ignored


It was as early as February 2017 when concerns about the conduct of US President Donald Trump's "man on the hill", Chris Collins, were first raised with regulators, including that he had allegedly contravened Australian corporations law. But local regulators chose not to act.



from Biotech News
Share:

7 Biotech Stocks With Big Upcoming Catalysts

7 Biotech Stocks With Big Upcoming Catalysts


Are you ready? Biotech stocks provide a compelling opportunity for risk-tolerant investors looking for rich rewards. Regardless of market sentiment, economic data or trade wars, a key regulatory approval or trial data can send prices rocketing.



from Biotech News
Share:

Finanzen: Aktien kaufen Schritt für Schritt : Aktien kaufen und verkaufen

Einen leichten Zugang zum Aktienhandel bietet der Direkthandel: Kurse gibt es in Echtzeit, Kosten sind transparenter und Aufträge werden am Stück ausgeführt. Wir zeigen Ihnen für unsere empfohlenen Depots, wie's geht.

from Finanztip Feed
Supported by Video Collection
Share:

Finanzen: Smartphone-Tarife : Smartphone-Tarife

Das alte Handy hielt ewig – aber irgendwann ist es Zeit für ein Smartphone mit Touchscreen. Das erfordert einen passenden Tarif.

from Finanztip Feed
Supported by Video Collection
Share:

Merck: Leichtes Umsatzwachstum auf Konzernebene

Merck: Leichtes Umsatzwachstum auf Konzernebene


Merck ist im 2. Quartal 2018 organisch solide gewachsen und hat trotz deutlich negativer Währungseffekte eine leichte Umsatzsteigerung erzielt. Das EBITDA pre sank im Vergleich zum Vorjahresquartal, ebenfalls belastet durch die Währungseffekte. Merck bestätigte seinen Ausblick für das Gesamtjahr 201...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.
Share:

Finanzen: Staffelmiete : Staffelmiete

Mit einer Staffelmiete nach § 557a BGB können Vermieter einfacher die Miete erhöhen. Doch ein Staffelmietvertrag birgt Nachteile für Mieter.

from Finanztip Feed
Supported by Video Collection
Share:

Heartland Advisors Inc. Has $4.33 Million Position in Trinity Biotech plc

Heartland Advisors Inc. Has $4.33 Million Position in Trinity Biotech plc


Heartland Advisors Inc. decreased its holdings in Trinity Biotech plc by 26.4% during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 865,400 shares of the company's stock after selling 310,420 shares during the quarter.



from Biotech News
Share:

Generikahersteller Mylan will wegen Problemen in USA neue Strategie ausloten

Generikahersteller Mylan will wegen Problemen in USA neue Strategie ausloten


(dpa-AFX) Der Preiswettbewerb unter den Herstellern von Nachahmermedikamenten in den USA beutelt anhaltend auch den Pharmakonzern Mylan. Im zweiten Quartal brachen die Umsätze des Generikaherstellers in Nordamerika um mehr als ein Fünftel ein, wie das Unternehmen am Mittwoch in Hertfordshire mitteil...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.
Share:

Evotec bestätigt Gewinnprognose trotz höherer Forschungsausgaben

Evotec bestätigt Gewinnprognose trotz höherer Forschungsausgaben


(dpa-AFX) Das Biotechunternehmen Evotec rechnet wegen des vor kurzem gegründeten Gemeinschaftsunternehmens mit Sanofi zur Bekämpfung von Infektionskrankheiten mit höheren Ausgaben für Forschung und Entwicklung. Im laufenden Jahr erwartet der Konzern jetzt Forschungs- und Entwicklungskosten von 35 bi...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.
Share:

Opioid-like antidepressant poisoning people, CDC warns; What is tianeptine? Source: Cox Media Group

Opioid-like antidepressant poisoning people, CDC warns; What is tianeptine? Source: Cox Media Group


Researchers at The Atlanta-based Centers for Disease Control and Prevention have issued a warning about the federally-unapproved antidepressant tianeptine. Poison control centers across the United States reported an increased number of calls between 2014-2017, "suggesting a possible emerging public health risk," CDC researchers wrote in the agency's Morbidity and Mortality Weekly Report .



from Biotech News
Share:

Unseriösen Verlagen ins Netz gegangen

Unseriösen Verlagen ins Netz gegangen


image description
„Predatory publisher“ oder Raubverlage waren bis vor kurzem noch relativ unbekannt – doch nun zeigt sich, welches Ausmaß diese unseriösen Anbieter auf die wissenschaftlichen Veröffentlichungen haben. Es lauert eine große Gefahr für die Glaubwürdigkeit der wissenschaftlichen Forschung. Viele Forscher...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.
Share: